MicroRNA | Cell type | Log2 fold change† | exploratory cohort P value | replication cohort P value | Previously validated target genes* | Pathways** | Diseases |
---|---|---|---|---|---|---|---|
miR-16-1-3p | CD4+ | 1.85 | 0.04 | 1.30E−05 | IGF1R, CREBBP, EXT1/2 | Autophagy | |
miR-28-5p | CD4+ | 1.15 | 3.06E−03 | 2.50E−04 | MAPK1, B7-H3 | Osteoblastic differentiation, JAK/STAT signaling pathway | |
miR-199a-5p | CD4+ | 2.11 | 3.20E−06 | 8.90E−04 | CEBP/α, HIF-1α, IKKβ, NFkB1, EXTL3, SMAD4, WNT2 | TGF-β, monocyte to macrophage differentiation, osteoclast differentiation, WNT signaling | AS [43] |
miR-126-3p | CD4+ | 1.74 | 6.57E−07 | 2.40E−03 | IκB, VCAM-1, LRP6, DNMT1, CXCL12 | NFκB, FcγR-mediated phagocytosis, HIF-1α signaling, PI3k/AkT signaling pathway | |
CD14+ | 1.24 | 0.03 | 0.04 | ||||
let-7d-3p | CD4+ | 1.24 | 0.02 | 3.10E−03 | |||
let-7b-5p | CD14+ | − 1.21 | 0.01 | 0.02 | IFNβ1, TLR4, SOX9, IL17RC, ERAP2 | PI3k/AkT signaling pathway, WNT signaling, Apoptosis | |
miR-361-3p | CD4+ | − 1.26 | 1.11E−03 | 4.80E−03 | LRP5, FRIZZLED6, TRAF1, IL1RA | WNT signaling | CD [72] |
CD14+ | − 1.35 | 1.08E−03 | 5.80E−05 | ||||
miR-484 | CD4+ | 1.2 | 5.24E−04 | 0.02 | IFNAR2, IL2, RUNX2 | Osteoblast differentiation | |
CD14+ | 1.22 | 9.89E−04 | 1.10E−03 | ||||
miR-16-5p | CD4+ | 1.11 | 3.91E−03 | 0.03 | WNT3A, LRP6, NFAT, SMAD3, BCL2, PDL-1, CASP1/5, IFNγ, EXT1/3, TNFAIP2, TGFB1, NFkB1, STAT3 | M1 macrophages polarization, T lymphocyte activation, TGF-β, PI3k/AkT and NOD pathways | |
CD14+ | 1.16 | 4.98E−03 | 1.20E−03 | ||||
miR-197-3p | CD4+ | 1.52 | 3.77E−04 | 0.03 | SMAD7, IL1R1, PDCD4, IL18 | TGF-B, Osteoclast differentiation, Apoptosis | |
miR-181c-5p | CD4+ | − 1.23 | 7.41E−03 | 0.04 | IL2, CCL22, IL1α, BCL2 | Apoptosis, FcγR mediated phagocytosis, PI3k/AkT signaling pathway | |
miR-874-3p | CD4+ | − 1.18 | 5.27E−04 | 0.05 | STAT3, IKKβ | Osteoblastic differentiation, FcγR mediated phagocytosis | |
miR-223-3p | CD14+ | 1.27 | 0.05 | 4.90E−04 | NLRP3, CLDN8, FOXO3, IL6 | Monocyte survival, macrophage differentiation, NFκB pathway, Epithelial cell adhesion | |
miR-146a-5p | CD14+ | − 1.31 | 0.08 | 2.01E−03 | NFκB, TRAF6, IRAK1, TLR2/4, STAT1, RORα, MAP3K7 | NFκB and TNFα pathways, cytokines production, myeloid lineage differentiation | |
miR-15a-5p | CD14+ | − 1.15 | 2.75E−04 | 4.60E−03 | BCL2, NFkB1, CARD8, TNFSF9, IKKα, SMAD7, IFNγ | PI3k/AkT and NOD-like signaling pathways, BCR and TCR signaling, NFkB, TLR signaling, osteoclast differenciation, Apoptosis | |
miR-376a-3p | CD14+ | 1.62 | 3.00E−06 | 6.05E−03 | CDK2, SMAD7, ATG4C, IL7 | Cell cycle, Bacterial invasion of epithelial cells, TGF-B pathway, Autophagy | |
miR-885-5p | CD14+ | 1.42 | 5.57E−03 | 0.01 | CDK2, CASP16, EGF1R, CLDN1 | Cell cycle, Epithelial cell adhesion, Bacterial invasion of epithelial cells | |
miR-574-3p | CD14+ | 1.35 | 1.78 E−03 | 1.89E−03 | RXRα, IRF4, EGFR | Chondrogenic differentiation, Ubiquitin mediated proteolysis | FMF [77] |
miR-92b-3p | CD14+ | 1.34 | 0.02 | 0.04 | SMAD2/5, BMP7, MAPK1 | Osteoblastic differentiation, TGF-B pathway | |
miR-30e-5p | CD14+ | − 1.18 | 9.06E−04 | 0.05 | BCL2, ATG12 | Apoptosis, autophagy |